STP-707

N/A

Report date: 2024/07/01 16:06:23
NME

Base Information

Drug NameSTP-707
Drug Alias NameSTP-707STP707
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceTransforming growth factor beta 1 inhibitorsCyclooxygenase-2 inhibitors
TargetsTransforming growth factor beta 1Cyclooxygenase-2
Therapy Area/IndicationsSolid tumoursPulmonary FibrosisLiver Cirrhosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSirnaomicsSirnaomics LtdSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPulmonary FibrosisLiver Cirrhosis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A